The influence of prolactin on bone mineral density (BMD) and some biochemical markers of ovariectomized rats

Czech Journal of Animal Science

Volumn 55, Issue 2, 2010, Pages 83-88

  Dolinska B ^a   Suszka Switek A ^b   Dragan, S ^c   Ryszka, F ^a   Kolacz R ^d   Patkowska Sokola B ^d  

^a Production Plant Biochefa   (Poland)

^b MEDICAL UNIVERSITY OF SILESIA   (Poland)

^c WROCLAW MEDICAL UNIVERSITY   (Poland)

^d WROC AW UNIVERSITY OF ENVIRONMENTAL AND LIFE SCIENCES   (Poland)

Author keywords

Bone mineral density (BMD); Experimental osteoporosis; Female rats; Femoral bone; Lumbar bone (12 14); Ovariectomy; Prolactin (prl)

Indexed keywords

ANIMALIA; RATTUS;

EID: 77749321423     PISSN: 12121819     EISSN: None     Source Type: Journal    
DOI: 10.17221/195/2009-cjas     Document Type: Article

References (22)

1. Adler R. A., Evani R., Mansouri A. (1998): Relative effects of prolactin excess and estrogen deficiency on bone in rats. Metabolism, 47, 425-428.
2. Briot K., Cortet B., Tremollieres F., Sutter B., Thomas T., Roux Ch., Audran M. (2009): Male osteoporosis: Diagnosis and fracture risk evaluation. Joint Bone Spine, 76, 129-133
3. Compston J., Cooper A., Cooper C., Francis R., Kanis J. A., Marsh D., McCloskey E. V., Reid D. M., Selby P., Wilkins M. (2009): Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK. Maturitas, 62, 105-108.
4. Delaney M. (2006): Strategies for the prevention and treatment of osteoporosis during early postmenopause. American Journal of Obstetrics and Gynecology, 194, 12-23.
5. Dróżdż M., Ryszka F., Pardela M. (1998): Prolactin (PRL) - a review of current and new perspectives of clinical use. Medical Science Monitor, 4, 191-194.
6. International Conference on Harmonization (ICH) (2006): Guide for Industry. Q2B. Validation of Analytical Procedures: Methodology, 1996. Available at: http://www.fda.gov/cder/guidance/index.htm
7. Kalu D. N. (1991): The ovariectomized rats as an animal model for postmenopausal bone loss. Bone Miner, 15, 175-92.
8. Kamel H. K. (2007): Update on osteoporosis management in long-term care: focus on bisphosphonates. Jamda, 8, 434-440.
9. Krishnamara N., Taweerathitan P. (1995): Acute effect of prolactin on active calcium absorption in rats. Canadian Journal of Physiology and Pharmacology, 73, 1185-1189.
10. Krishnamara N., Lotinum S., Limlomwongse L. (1993): Acute effect and mechanism of action of prolactin on the in situ passive calcium absorption in rat. Bone and Mineral, 23, 253-66.
11. 45Ca accumulation in rats. Endocrine Journal, 44, 257-264.
12. MengYong Z., Caijiao W., HuSheng Z., XianWu P., JinaMin F. (2008): Protective effect of polysaccharides from morinda officinalis on bone loss in ovariectomized rats. International Journal of Biological Macromolecules, 43, 276-278.
13. 3 metabolites and prolactin or growth hormone levels in rat. Pharmacol-Toxicol, 72, 188-193.
14. Nicoll C. S. (1980): Ontogeny and evaluation of prolactin's function. Federation Proceedings, 39, 2563-2570.
15. Peng Z. Q., Vaananen H. K., Zhang H. X., Tuukkanen J. (1997): Long-term effect of ovariectomy on the mechanical properties and chemical composition of rat bone. Bone, 20, 207-212.
16. Pinkerton J. V., Dalkin A. C. (2007): Combination therapy for treatment of osteoporosis: a review. American Journal of Obstetrics, 10, 559-565.
17. Roux C., Kolta S., Chappard C., Morieux C., Dougados M., De Vernejoul M. C. (1996): Bone effect of dydrogestrone in ovariectomized rats: a biologic, histomorphometric and densitometric study. Bone, 19, 463-468.
18. Ryszka F., Krupej J., Dolińska B. (1995): Biological accessibility and distribution of calcitonin in rats with experimental osteoporosis. Pharmazie, 9, 636-637.
19. Ryszka F., Dolińska B., Suszka-Świtek A. (2002): Distribution of prolactin in selected rat organs and tissues. International Journal of Tissue Reactions, 1, 99-102.
20. Scotti M. L., Langenheim J. F., Tomblyn S., Springs A. E. B., Chen W. Y. (2008): Additive effects of a prolactin receptor antagonist, G129R, and herceptin on inhibition of HER2-overexpressing breast cancer cells. Breast Cancer Research and Treatment, 111, 241-250.
21. Tanrattana Ch., Charoenphandhu N., Limlomwongse L., Krishnamra N. (2004): Prolactin directly stimulated the solvent drag-induced calcium transport in the duodenum of female rats. Biochimica and Biophysica Acta, 1665, 81-91.
22. 1 mice. International Immunopharmacology, 7, 1808-1812.